Citigroup’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.16M Sell
31,820
-81,308
-72% -$2.96M ﹤0.01% 2424
2025
Q1
$4.1M Buy
113,128
+46,207
+69% +$1.67M ﹤0.01% 1553
2024
Q4
$2.82M Buy
66,921
+23,428
+54% +$986K ﹤0.01% 1877
2024
Q3
$2.42M Buy
43,493
+23,018
+112% +$1.28M ﹤0.01% 1894
2024
Q2
$842K Sell
20,475
-136,374
-87% -$5.6M ﹤0.01% 2366
2024
Q1
$7.32M Buy
156,849
+46,339
+42% +$2.16M ﹤0.01% 1054
2023
Q4
$5.28M Buy
110,510
+19,930
+22% +$953K ﹤0.01% 1098
2023
Q3
$3.23M Buy
90,580
+19,113
+27% +$681K ﹤0.01% 1228
2023
Q2
$3.3M Sell
71,467
-84,568
-54% -$3.9M ﹤0.01% 1346
2023
Q1
$6.26M Buy
156,035
+62,510
+67% +$2.51M ﹤0.01% 1014
2022
Q4
$4.33M Sell
93,525
-39,859
-30% -$1.85M ﹤0.01% 1112
2022
Q3
$5.52M Buy
133,384
+48,918
+58% +$2.03M ﹤0.01% 1075
2022
Q2
$5.04M Buy
84,466
+61,083
+261% +$3.64M ﹤0.01% 1125
2022
Q1
$1.7M Sell
23,383
-35,565
-60% -$2.58M ﹤0.01% 1916
2021
Q4
$4.96M Buy
58,948
+29,199
+98% +$2.46M ﹤0.01% 1290
2021
Q3
$2.68M Sell
29,749
-25,416
-46% -$2.29M ﹤0.01% 1702
2021
Q2
$5.26M Buy
55,165
+7,137
+15% +$680K ﹤0.01% 1384
2021
Q1
$5.47M Buy
48,028
+6,061
+14% +$690K ﹤0.01% 1291
2020
Q4
$5.81M Buy
41,967
+35,927
+595% +$4.97M ﹤0.01% 1186
2020
Q3
$496K Sell
6,040
-31,334
-84% -$2.57M ﹤0.01% 2251
2020
Q2
$2.92M Sell
37,374
-11,768
-24% -$920K ﹤0.01% 1364
2020
Q1
$2.18M Buy
49,142
+28,701
+140% +$1.27M ﹤0.01% 1335
2019
Q4
$873K Sell
20,441
-40,759
-67% -$1.74M ﹤0.01% 2291
2019
Q3
$2.62M Buy
61,200
+28,565
+88% +$1.22M ﹤0.01% 1434
2019
Q2
$2.07M Buy
32,635
+7,758
+31% +$493K ﹤0.01% 1600
2019
Q1
$1.73M Sell
24,877
-101,404
-80% -$7.04M ﹤0.01% 1597
2018
Q4
$5.49M Buy
126,281
+8,370
+7% +$364K 0.01% 969
2018
Q3
$9M Buy
117,911
+106,049
+894% +$8.1M 0.01% 744
2018
Q2
$911K Sell
11,862
-24,017
-67% -$1.84M ﹤0.01% 1938
2018
Q1
$1.83M Sell
35,879
-5,240
-13% -$267K ﹤0.01% 1481
2017
Q4
$1.91M Buy
41,119
+16,703
+68% +$775K ﹤0.01% 1515
2017
Q3
$1.3M Sell
24,416
-7,758
-24% -$413K ﹤0.01% 1763
2017
Q2
$2M Buy
32,174
+13,278
+70% +$825K ﹤0.01% 1494
2017
Q1
$1.28M Sell
18,896
-110,048
-85% -$7.45M ﹤0.01% 1739
2016
Q4
$9.07M Buy
128,944
+116,454
+932% +$8.19M 0.01% 694
2016
Q3
$886K Buy
12,490
+3,555
+40% +$252K ﹤0.01% 2020
2016
Q2
$437K Sell
8,935
-27,950
-76% -$1.37M ﹤0.01% 2332
2016
Q1
$2.34M Buy
36,885
+24,554
+199% +$1.55M ﹤0.01% 1314
2015
Q4
$1.38M Buy
12,331
+10,163
+469% +$1.14M ﹤0.01% 1557
2015
Q3
$209K Sell
2,168
-780
-26% -$75.2K ﹤0.01% 2757
2015
Q2
$301K Sell
2,948
-5,203
-64% -$531K ﹤0.01% 2486
2015
Q1
$506K Sell
8,151
-1,025
-11% -$63.6K ﹤0.01% 2287
2014
Q4
$403K Buy
9,176
+8,306
+955% +$365K ﹤0.01% 2624
2014
Q3
$49K Buy
870
+545
+168% +$30.7K ﹤0.01% 3694
2014
Q2
$14K Buy
325
+301
+1,254% +$13K ﹤0.01% 4388
2014
Q1
$1K Buy
+24
New +$1K ﹤0.01% 5332